Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED‐HF)
Open Access
- 1 March 2013
- journal article
- research article
- Published by Wiley in European Journal of Heart Failure
- Vol. 15 (3), 334-341
- https://doi.org/10.1093/eurjhf/hfs204
Abstract
Aims This report describes the baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED‐HF) which is testing the hypothesis that anaemia corre...Keywords
This publication has 47 references indexed in Scilit:
- Coronary-Artery Bypass Surgery in Patients with Left Ventricular DysfunctionNew England Journal of Medicine, 2011
- Eplerenone in Patients with Systolic Heart Failure and Mild SymptomsNew England Journal of Medicine, 2011
- Asialoerythropoietin to Protect the Failing Heart: Is it Possible to Run With the Hare and Hunt With the Hounds?Journal of the American College of Cardiology, 2010
- Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled studyThe Lancet, 2010
- Ferric Carboxymaltose in Patients with Heart Failure and Iron DeficiencyNew England Journal of Medicine, 2009
- Effects of Exercise Training on Health Status in Patients With Chronic Heart FailureJAMA, 2009
- Anemia in chronic heart failure: etiology and treatment optionsCurrent Opinion in Cardiology, 2008
- Rosuvastatin in Older Patients with Systolic Heart FailureNew England Journal of Medicine, 2007
- Correction of Anemia with Epoetin Alfa in Chronic Kidney DiseaseNew England Journal of Medicine, 2006
- Anemia as a risk factor and therapeutic target in heart failureJournal of the American College of Cardiology, 2004